EUCTR2011-003630-13-NL进行中（未招募）不适用
99mTc labelled anti-TNF-alpha for the imaging of disease activity in pulmonary sarcoidosis - TISS
Sint Antonius Hospital0 个研究点开始时间: 2011年11月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Men and women > 18 years
- •Histological proof of sarcoidosis
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •A history of hypersensitivity to infliximab
- •Treatment with systemic corticosteroids or other immunosuppressive drugs in the year prior to screening
- •Previous diagnosis of auto-immune disease
- •Pregnancy or nursing
- •Mental health problems interfering with participation
研究者
相似试验
进行中（未招募）
1 期
Scintigraphic detection of tumor necrosis factor with radioactive labeled TNFa-blocker in patients with active rheumatoid arthritis and active axial and peripheric spondyloarthropathy.EUCTR2009-017998-37-BEGhent University Hospital36
进行中（未招募）
不适用
Diagnostic use of 99mTecnetium labeled infliximab in Crohn’s diseaseEUCTR2013-005629-21-HUFirst Department of Medicine, University of Szeged
进行中（未招募）
不适用
/AMedDRA version: 18.0Level: PTClassification code 10062909Term: Netherton's syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2013-002205-54-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
进行中（未招募）
1 期
Biomarkers identification of efficacy in Ankylosing SpondylitisAnkylosing SpondylitisEUCTR2013-004406-25-PTFaculdade de Ciências Médicas da Universidade Nova de Lisboa70
已完成
2 期
Infliximab effectiveness in COVID-19 patientsIRCT20201229049873N1Shahre-kord University of Medical Sciences40